SCHEMBL14974166

SCHEMBL14974166

O=c1[nH]c2ccc[c]c2c(=O)n2cccc12

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 14/20 0.57
TP53 P04637 1/20 0.49
MAP4K4 O95819 2/20 0.36
TAOK1 Q7L7X3 2/20 0.36
CDC7 O00311 1/20 0.36
PLK4 O00444 1/20 0.36
AURKA O14965 1/20 0.36
MAPK13 O15264 1/20 0.36
PDPK1 O15530 1/20 0.36
DYRK3 O43781 1/20 0.36
PRKD3 O94806 1/20 0.36
PAK4 O96013 1/20 0.36
ERBB2 P04626 1/20 0.36
NTRK1 P04629 1/20 0.36
PRKCG P05129 1/20 0.36
FYN P06241 1/20 0.36
CSF1R P07333 1/20 0.36
RET P07949 1/20 0.36
IGF1R P08069 1/20 0.36
ROS1 P08922 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7276765 0.74 PARP1 (0.69) PARP1TP53NTRK1NTRK3ALDH1A1
SCHEMBL29673205 0.73 PARP1 (1.00) PARP1TP53MAP4K4TAOK1CDC7
SCHEMBL1133601 0.73 PARP1 (1.00) PARP1TP53MAP4K4TAOK1CDC7
SCHEMBL38236 0.66 KDM4E (0.48) PARP1CDC7GSK3BALDH1A1KDM4E
SCHEMBL30902522 0.66 TP53 (1.00) PARP1TP53MAP4K4TAOK1CDC7
SCHEMBL14361434 0.66 PARP1 (0.60) PARP1TP53MAP4K4TAOK1CDC7
SCHEMBL30809703 0.66 PDE2A (0.67) PARP1TP53POLBGRIN2DGRIN3B
SCHEMBL9415441 0.66 PARP1 (0.60) PARP1TP53MAP4K4TAOK1CDC7
SCHEMBL22046017 0.66 TP53 (0.77) PARP1TP53MAP4K4TAOK1CDC7
SCHEMBL8566230 0.66 PDE2A (0.67) PARP1TP53POLBGRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2576536-B1 HAEMATOPOIETIC-PROSTAGLANDIN D2 SYNTHASE INHIBITORS UNIV QUEENSLAND (AU) 2016-09-14 EP disclosed
US-9199976-B2 Haematopoietic-prostaglandin D2 synthase inhibitors THE UNIVERSITY OF QUEENSLAND (AU) 2015-12-01 US disclosed
US-20130137684-A1 HAEMATOPOIETIC-PROSTAGLANDIN D2 SYNTHASE INHIBITORS THE UNIVERSITY OF QUEENSLAND (AU) 2013-05-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137684-A1 HAEMATOPOIETIC-PROSTAGLANDIN D2 SYNTHASE INHIBITORS HPGDS, PTGES, PTGIS PARP1 1089/4885TP53 2786/4885MAP4K4 2484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.